PSA - prijevod na Hrvatskom

• psa
• psorijatičnog artritisa
• s psa-om

Primjeri korištenja Psa na Engleski i njihovi prijevodi na Hrvatskom

Within the RA, PsA, AS, and nr-Axial SpA pivotal trials, one patient in an RA trial with pre-existing liver abnormalities
U sklopu pivotalnih ispitivanja u bolesnika s RA, PsA, AS i aksijalnim spondiloartritisom bez radiološkog dokaza, u jednog bolesnika

Across the Phase III RA, PsA and AS studies through week 52,
U ispitivanjima faze III u bolesnika s RA, PsA i AS do 52. tjedna protutijela na golimumab,

Although concomitant use of MTX results in higher steady-state trough concentrations of Simponi in patients with RA, PsA or AS, the data do not suggest the need for dose adjustment of either Simponi
Iako istodobna primjena metotreksata(MTX) rezultira povećanim koncentracijama lijeka Simponi u stanju dinamičke ravnoteže u bolesnika s RA, PsA ili AS, podaci pokazuju da nema potrebe za prilagodbom doze ni lijeka Simponi

During the Simponi Phase IIb and Phase III clinical trials in RA, PsA and AS, the incidence of lymphoma in Simponi-treated patients was higher than expected in the general population.
Tijekom kliničkih ispitivanja lijeka Simponi faze IIb i faze III u bolesnika s RA, PsA i AS, incidencija limfoma u bolesnika liječenih lijekom Simponi bila je viša od one očekivane u općoj populaciji.

In controlled Phase IIb and/or III trials in RA, PsA, AS, nr-Axial SpA, severe persistent asthma,
U kontroliranim ispitivanjima faze IIb i/ ili faze III u bolesnika s RA, PsA, AS, aksijalnim spondiloartritisom bez radiološkog dokaza

In the controlled and uncontrolled periods of the RA and PsA pivotal trials, with a median follow-up of approximately 5 years,
U kontroliranim i nekontroliranim razdobljima pivotalnih ispitivanja u bolesnika s RA i PsA, s medijanom praćenja od približno 5 godina,

In the controlled period of RA, PsA, AS, and nr-Axial SpA trials, serious infections were observed
U kontroliranom razdoblju ispitivanja u bolesnika s RA, PsA, AS i aksijalnim spondiloartritisom bez radiološkog dokaza,

In the controlled period of the pivotal trials in RA, PsA, AS, nr-Axial SpA, and UC, upper respiratory tract
U kontroliranom razdoblju pivotalnih ispitivanja u bolesnika s RA, PsA, AS, aksijalnim spondiloartritisom bez radiološkog dokaza

Phase III clinical trials in RA, PsA, AS, and UC, the incidence of non-lymphoma malignancies(excluding non-melanoma skin cancer)
Simponi faze IIb i faze III u bolesnika s RA, PsA, AS i UC, incidencija malignih bolesti koje nisu

In the Phase III studies in RA, PsA, AS, and UC, no overall differences in adverse events(AEs), serious adverse events(SAEs), and serious infections in patients age 65
U ispitivanjima faze III u bolesnika s RA, PsA, AS i UC općenito nije bilo razlika što se tiče ukupnih štetnih događaja, ozbiljnih štetnih događaja

Patients with RA, PsA or AS who did not receive concomitant MTX had approximately 30% lower steady-state trough concentrations of golimumab than those who received golimumab with MTX.
Bolesnici s RA, PsA ili AS koji istodobno nisu primali MTX imali su oko 30% manje koncentracije golimumaba u stanju dinamičke ravnoteže od onih koji su uz golimumab primali i MTX.

patients in two randomised, double-blind, placebo-controlled studies in patients with active PsA(≥ 5 swollen joints and≥ 5 tender joints)
placebom kontrolirana ispitivanja u bolesnika s aktivnim PsA(≥ 5 otečeni zglobovi i ≥ 5 bolni zglobovi)

reduce the rate of progression of peripheral joint damage in adult patients with active PsA.
smanjuje stopu progresije oštećenja perifernih zglobova u odraslih bolesnika s aktivnim PsA.

For patients with enthesitis and/or dactylitis at baseline, in PsA Study 1 significant improvement in enthesitis and dactylitis score was
Kod bolesnika s entezitisom i/ili daktilitisom na početku liječenja u PsA ispitivanju 1, zabilježeno je značajno poboljšanje bodova za entezitis

In PsA Study 2 significant improvement in enthesitis score
U PsA ispitivanju 2, značajno poboljšanje bodova za entezitis

the TRADUKI-sponsored collection of stories for young people, Prostor za mokrog psa, which originated from a GRAD short story competition, was presented at the GRAD Cultural Centre in Belgrade.
predstavljena je od TRADUKI-ja potpomognuta zbirka pripovjedaka za mlade Prostor za mokrog psa, koja je proizišla iz natječaja za kratku priču kulturnog centra GRAD.

which will be published at the end of June 2012 with the financial backing of TRADUKI in a collection entitled Prostor za mokrog psa.
odabrao je 17 pripovjedaka koje će se uz TRADUKI-jevu financijsku pomoć krajem lipnja 2012. objaviti u zbirci s naslovom Prostor za mokrog psa.

der Heijde-Sharp score(vdH-S score), modified for PsA by addition of hand distal interphalangeal joints,
promjena ukupnog van der Heijde- Sharp-ovog boda(vdH-S score), modificirano za PsA uz dodavanje distalnih interfalangealnih zglobova šake,

PALACE 3) of similar design in adult patients with active PsA(≥ 3 swollen joints and≥ 3 tender joints)
sličnog dizajna u odraslih bolesnika s aktivnim psorijatičnim artritisom(≥ 3 otečena zgloba i ≥ 3 bolna zgloba)

In the controlled period of RA and PsA pivotal trials, mild ALT elevations(> 1 and< 3 x upper limit of normal(ULN))
U kontroliranom razdoblju pivotalnih ispitivanja u bolesnika s RA i PsA blago povećanje razine ALT-a(>